Involving patients, families and medical staff in the evaluation of 3D printing models of congenital heart disease by Biglino, Giovanni et al.
                          Biglino, G., Capelli, C., Leaver, L. K., Schievano, S., Taylor, A. M., &
Wray, J. (2016). Involving patients, families and medical staff in the
evaluation of 3D printing models of congenital heart disease. Communication
and Medicine, 12(2-3), [28455]. https://doi.org/10.1558/cam.28455
Peer reviewed version
Link to published version (if available):
10.1558/cam.28455
Link to publication record in Explore Bristol Research
PDF-document
This is the accepted author manuscript (AAM). The final published version (version of record) is available online
via De Gruyter at http://dx.doi.org/10.1558/cam.28455 . Please refer to any applicable terms of use of the
publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
 1 
 
Cover Sheet 
 
Authors: Giovanni Biglino1,2, Claudio Capelli1,2, Lindsay-Kay Leaver2, Silvia 
Schievano1,2, Andrew M. Taylor1,2 and Jo Wray2 
 
Affiliations: 1University College London, UK; 2Great Ormond Street Hospital for 
Children, London, UK 
 
Full Address: 1Institute of Cardiovascular Science, University College London, 
London WC1E 6BT, United Kingdom; 2Cardiorespiratory Division, Great Ormond 
Street Hospital for Children, NHS Foundation Trust, London WC1N 3JH, United 
Kingdom 
 
Email: g.biglino@ucl.ac.uk and g.biglino@bristol.ac.uk  
 
Full title of article: Involving patients, families and medical staff in the evaluation of 
3D printing models of congenital heart disease  
 
Short title of article: Stakeholder involvement to evaluate 3D printing models 
 
Word Count (all inclusive): 5,361  
Character Count (with spaces): 35,895 
 
 
 
 
 
  
 2 
 
Bionotes  
 
 
Giovanni Biglino studied bioengineering at Imperial College London, has a PhD in 
cardiovascular mechanics from Brunel Institute of Bioengineering and a diploma in 
biostatistics from Harvard Medical School. He is currently working at University 
College London on modelling of congenital heart disease as part of a fellowship with 
the National Institute of Health Research (NIHR). Address for correspondence: Great 
Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK. 
Email: g.biglino@ucl.ac.uk 
 
Claudio Capelli graduated in biomedical engineering from Politecnico di Milano and 
gained his PhD from University College London. His research interests involve patient-
specific computational simulations, 3D modelling from medical imaging and structural 
simulation for studying medical devices. Address for correspondence: Great Ormond 
Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK. Email: 
c.capelli@ucl.ac.uk 
 
Lindsay-Kay Leaver is the Adolescent Nurse Specialist at Great Ormond Street 
Hospital. Her research focuses on loss to follow-up. She runs workshops with patients 
and liaises with charities and organisations to support their development into 
independent individuals. Address for correspondence: Great Ormond Street Hospital 
for Children, Great Ormond Street, London WC1N 3JH, UK. Email: Lindsay-
Kay.Leaver@gosh.nhs.uk 
 
Silvia Schievano is a Senior Lecturer in Biomedical Engineering at University College 
London. Her main research interest is patient-specific modelling for cardiovascular 
applications (particularly cardiovascular devices) and for craniofacial modelling. She 
 3 
 
pioneered the use of 3D printing for testing devices during the development of the 
Melody Valve (®Medtronic), a percutaneous pulmonary device. Address for 
correspondence: Great Ormond Street Hospital for Children, Great Ormond Street, 
London WC1N 3JH, UK. Email: s.schievano@ucl.ac.uk 
 
Andrew M. Taylor is a Professor of Cardiovascular Imaging at the UCL Institute of 
Cardiovascular Science, and Divisional Director and Cardiac Academic Lead of 
Cardiorespiratory Services at Great Ormond Street Hospital for Children. Address for 
correspondence: Great Ormond Street Hospital for Children, Great Ormond Street, 
London WC1N 3JH, UK. Email: a.taylor76@ucl.ac.uk 
 
Jo Wray is a Health Psychologist and a Senior Research Fellow at Great Ormond Street 
Hospital. Her PhD research focused on the psychological impact of congenital heart 
disease and cardiac surgery for children and families. She has worked with paediatric 
transplant patients and leads on psychosocial research and patient-reported outcomes 
and experiences in the Critical Care and Cardiorespiratory Division at Great Ormond 
Street Hospital. Address for correspondence: Great Ormond Street Hospital for 
Children, Great Ormond Street, London WC1N 3JH, UK. Email: jo.wray@gosh.nhs.uk 
  
 4 
 
Abstract 
Objective: To develop a participatory approach in the evaluation of 3D printed patient-
specific models of congenital heart disease (CHD) with different stakeholders who 
would potentially benefit from the technology (patients, parents, clinicians and nurses).  
Methods: Workshops, focus groups and teaching sessions were organized, targeting 
different stakeholders. Sessions involved displaying and discussing different 3D 
models of CHD. Model evaluation involved response counts from questionnaires and 
thematic analysis of audio-recorded discussions and written feedback.  
Results: Stakeholders’ responses indicated the scope and potential for clinical 
translation of 3D models. As tangible, three-dimensional artefacts, these can have a role 
in communicative processes. Their patient-specific quality is also important in relation 
to individual characteristics of CHD. Patients indicated that 3D models can help them 
visualise “what’s going on inside”. Parents agreed that models can spark curiosity in 
the young people. Clinicians indicated that teaching might be the most relevant 
application. Nurses agreed that 3D models improved their learning experience during a 
CHD course.  
Conclusion: Engagement of different stakeholders to evaluate 3D printing technology 
for CHD identified the potential of the models for improving patient-doctor 
communication, patient empowerment and training.  
Practice Implications: A participatory approach could benefit the clinical evaluation 
and translation of 3D printing technology. 
 
 
 
Keywords 
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1. Introduction 
Patient-doctor communication is recognised as an essential part of clinical practice 
(Travaline et al. 2005). Improved communication strategies can aid in achieving what 
has been defined as a triple aim of improving quality of care, reducing costs and 
enhancing patient experience (Gordon et al. 2015). New technologies can enrich and 
facilitate such communication strategies, particularly by improving connectivity and 
enabling a better flow of information (Gordon et al. 2015). One technology that can 
play a role in this context is three-dimensional (3D) printing technology, i.e. the 
capability of manufacturing a suitable input file into a 3D object by printing it layer by 
layer at a fine resolution. The potential benefits of 3D printing in medicine are indeed 
multiple, ranging from the educational domain to improving decision-making, from 
patient-specific implants to aiding in communication (Biglino et al. 2011; Costello et 
al. 2015).  
An area that lends itself to the use of a personalised approach is congenital heart 
disease (CHD). This is mainly due to a) the anatomical complexity and small 
dimensions of congenital defects (vascular and intra-cardiac) and b) the unique nature 
of the cases that do not warrant a standardised approach but rather a patient-specific 
approach. In particular, it could be argued that by using a 3D replica to better visualise 
the congenital defect being discussed, these tools could improve the quality of 
communication between clinicians and patients and their families. The invisible nature 
of CHD and its complexity are known to lead to misperceptions and knowledge gaps 
in patients that are affected (Verstappen et al. 2006; Chiang et al. 2015). The potential 
of 3D printing technology to make the invisible visible can have beneficial 
repercussions on communication strategies and, in turn, on understanding of CHD.  
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Little evidence has been collected to this end. One recent study (Biglino et al. 
2015) targeted a group of parents of children with CHD to evaluate conventional 
communication vs. communication aided by a 3D model. This study showed that 
parents appreciated and responded well to the models. They found models more 
immediate than medical images and more helpful for their understanding of the defect, 
but their short-term knowledge of the main features of the CHD did not appear to 
improve as a result of exposure to the models. In the same study, cardiologists equally 
valued the 3D replicas, and found them useful in discussing the defect with the families; 
however, consultations had a longer duration on average than when models were not 
used. As both expert and non-expert users demonstrated interest in the technology, 
more research is warranted to evaluate its full value in aiding communication.  
The aim of this study was to collect feedback from representative stakeholders 
in order to better inform the next steps in the evaluation of clinical translation of 3D 
printing technology for CHD.  
 
2. Literature review 
Early evidence of the effects of good patient-doctor communication included the 
positive impact on patient outcomes such as pain and anxiety; physiological parameters 
such as blood pressure and glucose levels; as well as patient satisfaction and patient 
adherence to treatment (Stewart et al. 1999). A review of the subject (Ha and 
Longnecker 2010) detailed several areas for improving communication, including: 
communication skills and training, collaborative communication (i.e. reciprocal two-
way exchange), addressing unspoken conflicts (e.g. in paediatric palliative care), and 
acknowledgement of divergent beliefs. The literature also discusses the shift from a 
more ‘paternalistic’ approach to shared decision-making and patient empowerment 
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(Teutsch 2003). Indeed, amongst key tasks in communicating with patients, it is 
important that the physician is able to elicit the patient’s main problems and perception 
of these, as well as tailoring information and verifying the patient’s understanding of 
the problem itself (Maguire and Pitcealthly 2002).  
Research in health is continually being shaped by the involvement of patients 
and the public (PPI) in participatory paradigms and an approach based on PPI has value 
for assessing the potential of 3D printing technology and its specific implementation in 
the field of CHD.  One theory which supports such a participatory approach is the 
theory of social construction of technology, which posits that technology is shaped by 
human action rather than being a determinant of it.  Furthermore, proponents of the 
theory argue that in order to understand how a technology is used it is necessary to 
understand how it is embedded in its social context.  One of the core concepts is that of 
interpretative flexibility, whereby each technological artefact is recognised as having 
different meanings and interpretations for different groups of people (e.g. users, 
designers etc).   
Within the wider literature on health and illness there are many examples of 
how a participatory approach has influenced technological design, and ultimately health 
outcomes.  One example is the recent development of a mobile health application to 
promote medication adherence and enhance communication about medical 
management in solid organ recipients (Shellmer et al. 2016).   The investigators in this 
latter study employed principles of user-centred design to iteratively develop and test 
the application, resulting in a product which adolescents expressed an interest in using 
and high levels of user satisfaction.  In a recent review of adolescents’ use of mobile 
and tablet applications to support their own management of their chronic health 
conditions, a consistent finding was that adolescents contribute to the design of the 
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applications (Majeed-Ariss et al. 2015).  Health professionals are also increasingly 
being engaged in the development of technology, which is recognised as important if 
the technology is going to be embedded into clinical practice (Aldiss et al. 2010). 
 
3. Materials and methods 
We identified four groups of stakeholders who would be able to make salient 
contributions to the evaluation of 3D printing of CHD: 
a) Patients with CHD, i.e. young people attending clinics, who are starting to take 
more responsibility for their own health and for whom it is crucial to enhance 
the quality of communication and ensure the best possible understanding of the 
condition for lifestyle adjustments and overall awareness;  
b) Parents of patients with CHD, who are also faced with the challenges of 
understanding the life-long complications of repaired CHD and caring for their 
children, particularly at younger ages; 
c) Clinicians, including cardiologists and cardiac surgeons, who can potentially 
use 3D patient-specific models to facilitate communication, as well as in the 
planning of different procedures and as an aid in decision-making; 
d) Trainees, particularly nurses, who require an in-depth knowledge of CHD 
morphology and complications to care for these often medically complex 
patients.  
Four workshops, one for each stakeholder group, were convened to collect user views 
on 3D printed models of CHD.  Each workshop was audio-recorded and 
contemporaneous notes made during the session. Ethical approval for the study was 
received from the National Research Ethics Service and all participants provided 
written consent for their participation and the use of the audio-recordings, if applicable.   
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a) Patients with CHD  
A group of patients with CHD (n=13) was invited from the cardiac transition clinic at 
our Centre. All patients (age range 14.8-18.5 years, 9 males) had repaired complex 
congenital heart disease, such as transposition of the great arteries, tetralogy of Fallot, 
coarctation of the aorta and Fontan-type circulation. Patients were invited to a 2-hour 
workshop. At the beginning of the workshop they received a brief explanation about 
how 3D patient-specific models are manufactured, starting from processing of 
cardiovascular magnetic resonance (CMR) image data. They were then invited to create 
3D heart models using play-doh, as an icebreaker activity. Finally, they were shown a 
range of 3D models of CHD, showcasing different defects and manufactured using 
different materials (summarised in Table 1). <INSERT TABLE 1 ABOUT HERE.> 
Samples of the models are shown in Figure 1. Patients were asked to freely discuss 
features of all the models they were shown and they were guided by two workshop 
facilitators, one of whom was an adolescent clinical nurse specialist and the other a 
biomedical engineer, during the discussion. 
<INSERT FIG. 1 ABOUT HERE.> 
 
b) Parents of patients with CHD 
Running concurrently with the patient workshop (group a), a second group was formed, 
composed of parents of patients with CHD (n=15, 9 mothers). Parents received the 
same brief explanation about how 3D patient-specific models are manufactured with 
the young people and were then invited into a separate room, in which they were first 
guided to discuss aspects of using 3D models of CHD in clinical practice, including:  
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• Any potential anxieties they had regarding their child’s response when he/she 
is shown a 3D model of his/her CHD; 
• Whether they thought 3D models could engage their child; and  
• Whether they had a preference for a lesion-specific model or a patient-specific 
model 
Parents were then shown the same range of models as the young people (Table 1) and 
invited to discuss features of the models. The workshop discussion was facilitated by 
two biomedical engineers. 
 
c) Clinicians  
A group of clinicians (n=14, 12 male) was invited to a 3-hour workshop titled “How to 
transform your 2D clinical images into a 3D printed model to guide procedures”. The 
workshop discussed technical aspects related to image processing and consequent 
creation of 3D models. Clinicians worked in fields related to cardiology (e.g. consultant 
cardiologists, CMR fellows, cardiology specialist registrars) and were asked to 
complete a brief questionnaire prior to and at the end of the workshop. The questions 
focused on evaluating the clinicians’ perception of 3D models of CHD and their 
willingness to adopt this tool in clinical practice.  Questions comprised forced choice, 
Likert scale and multiple-choice responses. Questions included whether they had 
previously used a 3D model and what kind of image data they had access to; would 
they use a patient-specific model in their practice; their level of agreement about 
whether 3D patient-specific models are helpful for planning interventions, teaching 
and/or testing devices; and a ranking of the most relevant potential applications, 
including teaching, planning procedures, communication with patients, and research.  
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d) Nurses 
A group of nurses (n=11, 11 female), who attended a foundation course in adolescent 
cardiac care at a specialist paediatric hospital, was asked to complete a questionnaire 
about the features of 3D models of CHD at the end of the course. The nurses were 
shown 8 models derived from patient-specific CMR data, representing the following 
anatomical arrangements: normal cardiac anatomy; repaired transposition of the great 
arteries; aortic coarctation; repaired tetralogy of Fallot; pulmonary atresia with intact 
ventricular septum; and hypoplastic left heart syndrome at all three stages of palliation 
(i.e. post Norwood procedure, post Glenn, and post total cavopulmonary connection). 
All models (Figure 2) were available to look at throughout the course and, at the end of 
the course, the nurses were asked to complete a short questionnaire to assess the 
usefulness of the models from a learning perspective. Questions included their level of 
agreement about whether 3D patient-specific models added to the learning experience; 
whether models are more informative than diagrams and drawings; whether 3D models 
are helpful for appreciating anatomical dimensions, spatial orientation of anatomical 
features, anatomical complexity, treatment and care for CHD patients; and a ranking of 
which models were most useful. Participants were also invited to provide additional 
free text feedback. <INSERT FIG. 2 ABOUT HERE.> 
 
Manufacturing the 3D models 
All models used in this study were patient-specific and derived from anonymised CMR 
data of patients with the condition of interest. Imaging data were processed with 
commercial software (Mimics, Materialise, Leuven, Belgium), as described previously 
(Schievano et al. 2007). The processed 3D data were exported in a stereolithography 
(.stl) format compatible with 3D printers. While models were specifically printed using 
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a range of different materials to identify preferences of participants in the patient and 
parent focus groups (Table 1), and this range of models was also shown to the 
clinicians’ group, the models that were used for teaching purposes with the nurses were 
all printed in white nylon as a neutral option, with the objective of focusing on the 
anatomy itself in this case.  
 
Analysis of workshop data 
The quantitative data from the questionnaires were analysed using descriptive statistics 
(frequencies, means). Participants’ free text comments were analysed using thematic 
analysis.  Free text comments from the questionnaires were entered into a spreadsheet 
and two authors independently coded the data before grouping the codes into 
meaningful themes.  The authors met and agreed a list of themes and checked back with 
the data to ensure that the themes accurately reflected the data. For the recordings from 
the workshops with patients and parents, a similar approach was adopted with two 
authors listening to the recordings several times, identifying codes and grouping the 
codes into themes.  
 
4. Results 
 
a) Patients  
Patients engaged well in the workshop, following a successful icebreaker activity 
involving making 3D hearts with play-doh (Figure 1). All participants were actively 
involved in the conversation, did not restrain from commenting when shown a model 
and did not openly show anxiety or discomfort in discussing 3D models. In discussing 
the models (Figure 1), patients specifically spoke about the value of the models in 
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enhancing their understanding of their heart condition.  They reported that the models 
were “clearer than CMR scans” and that they “help [to] visualise what’s going on 
inside”. Patients also thought 3D models could be “useful for explaining [their heart 
condition] to [their] siblings”.  Patients unanimously agreed that the addition of 
computational/visual information on a computer to that provided by the 3D rapid 
prototyping model would be desirable; however, when asked to choose between a 3D 
rapid prototyping model and a virtual one, the majority (10 out of 13) opted for the 3D 
rapid prototyping model. 
With regard to the features of the models, young people reported that 
transparent models “help you imagine blood travelling through the arteries”. They also 
suggested the use of several colours (“not just red and blue”) to label different 
anatomical structures (e.g. heart chambers, vessels) and the defect itself. One 
participant commented that “red can be shocking”. Almost all patients (12 out of 13) 
agreed that a real size model is more informative than an enlarged version.  
 
b) Parents  
Parents also engaged well in the discussion with the workshop facilitators (Figure 3), 
providing eloquent responses, generously sharing their experience in a relaxed 
conversation. Only 2 out of 15 parents expressed some concern at the prospect of their 
children being shown their 3D patient-specific model. The focus of their concern was 
that their children could potentially be distressed at the sight of a realistic model. 
Parents unanimously agreed that models could stimulate curiosity and engage their 
children at the time of transition clinic. They preferred the idea of a patient-specific 
model rather than a lesion-specific model, with several saying that the diagnosis of their 
children is “complex congenital heart disease” and therefore that a lesion-specific 
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model would not be a sufficient representation. Parents also indicated that it would be 
desirable to have a control model (i.e. normal cardiac anatomy) to further highlight 
what components/dimensions are different or are affected in their child.  
<INSERT FIG. 3 ABOUT HERE.> 
Regarding the features of the models themselves (Table 1), 13 out of the 15 
parents did not have a preference for any one of the three white aortic models, but 2 
participants did not like the white models printed in Nylon (“they feel too fragile”), and 
when shown the four models of the right ventricular outflow tract made in different 
materials, 13 out of 15 parents preferred those in TangoPlus® (i.e. rubber-like) as they 
“feel more real”. They unanimously agreed that transparent models would be helpful 
to show the route of a catheter or the position of a valve. They also unanimously agreed 
that the red colour did not add information for a single anatomical component (e.g. 
aorta), and the lesion could actually be better appreciated on white models; however, 
when more than one anatomical component was included in the model (e.g. right and 
left heart), a colour model (i.e. red and blue) was thought to be better. They indicated 
that they were familiar with red and blue models from school, books and pamphlets. 
From a methodological perspective, parents indicated that any future research 
to study models with their children should be somewhat interactive, e.g. using iPads to 
show visual information to a technologically competent young generation.  
 
c) Clinicians 
Prior to the workshop, clinicians reported that they did not feel very well informed 
about 3D printing (average self-reported knowledge = 3.9±1.7 on a scale 1-10). Four 
clinicians reported that they had used a 3D model previously. When discussing the 
usefulness of patient-specific models for practicing/planning interventions, teaching 
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and testing new devices, clinicians generally agreed or strongly agreed that models 
could be a valuable tool (Figure 4), particularly for teaching purposes and less so for 
testing new devices. <INSERT FIG. 4 ABOUT HERE.> When asked whether they 
would use a 3D model in their own practice, 7 out of 14 strongly agreed and 6 out of 
14 agreed, with only one participant remaining neutral. Interestingly, clinicians ranked 
teaching as the most relevant potential application of 3D models, while communication 
was ranked as least relevant (Figure 5). <INSERT FIG. 5 ABOUT HERE.> 
 
d) Nurses  
Overall, nurses reported that the use of patient-specific models improved their leaning 
experience (9 agreed, 2 strongly agreed) and they found models to be more informative 
than diagrams and sketches (9 agreed, 2 neutral). Nurses agreed that 3D models are 
helpful for understanding the anatomy (11 out of 11), spatial orientation (9 out of 11) 
and complexity post surgical repair (8 out of 11). However, they were more ambiguous 
with regard to how helpful they thought the models were as an aid to understanding 
treatment and care for patients with CHD (6 out of 11). When comparing patient-
specific models with generic (or lesion-specific) models the response was inconclusive, 
with some nurses agreeing and some disagreeing that patient-specific models provide 
more information, and 3 out of 11 nurses found the patient-specific models somewhat 
confusing in this regard. In terms of the range of CHDs that were modelled, all were 
found to be useful or very useful, with those conditions requiring understanding of the 
pulmonary valve and right ventricular outflow tract scoring as least helpful (Table 2). 
While the models were all purposefully printed in white nylon for this group of nurses, 
five participants pointed out in their written feedback that different colours would have 
been helpful.  
 17 
 
<INSERT TABLE 2 ABOUT HERE.> 
    
5. Discussion and conclusion 
 
5.1. Discussion  
Rapid prototyping technology can have a revolutionary impact in medical practice, 
although it still poses regulatory concerns as well as ethical and technical challenges 
(Maruthappu and Keogh 2014). The possibility of replicating the human anatomy in 
3D can potentially help patients and their families visualise complex anatomical 
features, improve their understanding of potential complications and have a better 
appreciation of the condition overall. This could be particularly relevant for the area of 
congenital heart disease (CHD), where the complexity of both anatomy and repairs 
warrants a patient-specific approach, which is an intrinsic advantage of rapid 
prototyping medical models. Intra-cardiac and/or vascular arrangement after CHD 
repair can be very different from normal cardiovascular anatomy and can vary 
considerably between patients with the same diagnosis; because of its high three-
dimensionality, spatial and dimensional understanding from images may be very 
limited, particularly for non-expert users; vessel dimensions can also be very small (< 
1 cm) in young patients. Preliminary research (Biglino et al. 2015) with parents of 
patients with CHD and their cardiologists showed that the models were generally liked 
by participants, although some results were more controversial, such as the lack of 
improvement in short-term parental knowledge and the extended duration of 
consultations.  It is evident that more in-depth studies are needed to further elucidate 
the clinical translation of this technology.  
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Within the framework of the theory of social construction of technology, a 
participatory approach is important for the implementation of this new technology. In 
the current study we engaged with both non-expert (i.e. patients and their parents, 
separately) and expert users (i.e. nurses and clinicians with a specialist background in 
paediatric cardiology or cardiac imaging) as key stakeholders in this technology.  
Patients agreed that models can be useful for improving their understanding, 
qualitatively, of their heart condition. This understanding can be further enhanced if the 
model is printed in real size (rather than scaled to an enlarged size, e.g. to maximise 
insight into the defect). They felt that 3D models could help in the communication 
process not just with clinicians, but also with other people such as other healthcare 
professionals (e.g. health visitor), friends and siblings. As a technology competent 
young generation, teenage patients liked the idea of potentially accessing additional 
information virtually (e.g. results from computational simulations shown on a screen). 
However, the majority still reported that if they had to choose between a virtual and a 
physical rapid prototyping model, they would prefer the physical model. We suggest 
that this might be related to the fact that not only does a 3D rapid prototyped model 
make visible something that is invisible (i.e. their CHD), but it also renders it tangible. 
The role of tangible artefacts in healthcare has been discussed previously, particularly 
in relation to supporting collaborative work and the effect on decision-making, within 
the framework of distributed cognition (Xiao 2005). In general terms this aspect relates 
to the materiality of the artefacts and the role of artefacts in communicative behaviours 
(Dant 2005).  
Elicitation of parents’ perspectives in the current workshop revealed that 
parents are generally not worried about the possibility of young people being shown 
their own models and potentially being shocked by them. In fact, they all thought that 
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patient-specific models could stimulate curiosity in young people and prompt them to 
ask questions. One important point raised by the parents was that they preferred a 
patient-specific model to a generic, lesion-specific model. In particular, they felt that a 
generic model of the lesion may not fully represent all of the features of their children’s 
anatomy, whereas a patient-specific model is a more useful tool in this regard.  
With regard to the actual models, both patients and parents liked transparent 
models, with patients commenting that transparency can help in imagining blood 
flowing through the vasculature and parents adding that it can be helpful in visualising 
the position of a device when discussing a procedure with a clinician. Parents 
appreciated compliant (i.e. rubber-like) models in particular, as they deemed them to 
be “more realistic”, while patients were more resistant to this kind of model and in fact 
some considered them to be “too realistic”. The possibility of using this kind of model, 
which can have other useful research applications (Biglino et al. 2013), should be 
explored further. Both patients and parents also liked colourful (i.e. red and blue) 
models, with which they were somewhat familiar, but they were not considered 
definitely superior to white models, particularly for those models that only involved 
one side of the circulation (e.g. left ventricle and aorta). Regarding the use of colours, 
patients suggested that using multiple colours might be helpful for highlighting 
different structures and the defect(s) being discussed, which would be feasible from a 
technical point of view (Yoo et al. 2014).  
Clinicians responded positively with respect to the use of 3D patient-specific 
models in clinical practice, particularly for teaching applications, which was ranked as 
the most relevant application of 3D models. Rapid prototyping models could be a 
valuable training tool, without the need for specimens, for a library of congenital heart 
defects. A recent study reported positive results in this regard, whereby 29 premedical 
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and medical students were exposed to a simulation-based educational curriculum using 
3D heart models, particularly focusing on the study of ventricular septal defects 
(VSDs). Students reported statistically significant improvements in knowledge 
acquisition, knowledge reporting, and structural conceptualization of VSDs (Costello 
et al. 2014). In contrast, in the current study use of the 3D model as an aid to 
communication was not prioritised by clinicians, and was ranked as least relevant 
amongst possible applications of 3D models. This might be due to the fact that 
clinicians still rely on medical images and sketches for communication purposes, but 
may also be reflective of clinicians’ confidence in their own consultation style 
(Williams et al. 1998). Whilst this does not undermine the communication potential of 
3D patient-specific models, it rather suggests that further engagement with the expert 
user is needed to determine how best to implement models as communication tools in 
clinical practice. 
This study supports using a participatory approach for the implementation of a 
novel tool (i.e. 3D patient-specific models). In general, PPI can be extremely valuable 
for many aspects of the research process, including prioritising research questions, 
providing the user perspective in steering groups, improving consent rates and 
ultimately enhancing the relevance, validity, quality and success of clinical research 
(Brett et al. 2014; Gamble et al. 2014; Taylor et al. 2015).  From a PPI perspective this 
study shows that the way in which groups are organised is important to ensure their 
success and hence gather relevant information to structure future studies and prioritize 
questions. The workshops with patients and parents were run successfully in an 
informal setting by bioengineers involved with 3D printing technology and an 
adolescent nurse specialist who knew the young people. Similarly, a workshop focused 
on more technical aspects related to medical imaging and 3D printing successfully 
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engaged a group of clinicians, in a more formal setting, again facilitated by 
bioengineers involved with 3D printing technology as well as experts in CMR physics. 
The workshop with the nurses was also run in a more formal setting, within the context 
of a course they were attending, with nurses generally responding well and indicating 
3D patient-specific models as useful tools for their learning and for understanding CHD 
anatomy. While this highlights the different settings chosen for different groups, the 
approach remains multidisciplinary throughout, involving bioengineers, clinicians, 
experienced nurses, and a psychologist in the organisation of the groups, and planning 
and running of the activities.  
One interesting aspect that should be explored in future work is the idea of a co-
researcher, particularly for young people with CHD, to improve the evaluation of this 
novel tool and explore further ways in which young people may use it, such as in 
providing informed consent/assent for medical procedures. This is based on the 
assumption that young people would feel more comfortable if a survey was 
administered by a person of similar age and/or a peer (in this case, another patient with 
CHD). As discussed in the literature, involving young people in study design, set-up 
and naming can influence the acceptability of the study and consent procedures, 
resulting in higher acceptance rates (Boote et al. 2010). Methodologically, it has been 
noted that a shift from research on children, through research with children to research 
by children is accompanying the changes in adult-child power and participation agendas 
(Kellett 2005). The involvement of young people as participatory researchers can lead 
to improved access to other young people. This approach can have the advantage of 
providing ‘insider knowledge’, but also the disadvantage that the participants’ potential 
emotional involvement in the subject-matter can be a cause of tension. Participatory 
research has also been identified as ‘empowerment research’ and has been proposed as 
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a practice that should be recognised and fostered (Toronto Group 2005). In terms of the 
sensitivity of ‘empowerment research’, guidelines have been put forward on how to 
involve children and young people in research; in the UK, this has been curated by the 
National Children’s Bureau (see: www.participationworks.org.uk). Patients and parents 
in our study responded favourably to the idea of a co-researcher, supporting the fact 
that this approach warrants further research and piloting.  
 
5.2. Limitations 
The small sample size of each of the stakeholder groups was small, precluding 
statistical analysis and also potentially limiting the generalizability of the findings.  
 
5.3. Conclusion  
This paper presented results describing the engagement of different stakeholders with 
the clinical translation of 3D printing technology for identifying model features and 
research questions of interest, particularly with regard to congenital heart disease. 
Benefits of 3D printing for CHD are, at present, only projected. In an effort to gather 
evidence to support or contradict their clinical use, PPI can provide access to important 
feedback from different stakeholders. Furthermore, a PPI-based approach in the 
evaluation and translation of 3D printing technology may in turn increase patient 
empowerment, improve patient-doctor communication and provide increased access to 
a new tool for teaching and training purposes. Future studies with larger sample sizes 
to enable appropriate statistical analysis should include a participatory approach in their 
design and ultimately focus on evaluating the actual clinical usefulness of the 
technology, which would include measuring variables such as patient satisfaction, 
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patient adherence/loss to follow-up, lifestyle adjustments, appropriateness of exercise 
levels, and, from the clinicians’ perspective, the impact on the decision-making process.  
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Table 1  
List of 3D cardiovascular models that were given to patients with CHD and parents of 
the patients to discuss, showcasing different parts of the anatomy and manufactured 
using different materials and colours.  
 
 
ANATOMY MATERIAL COLOUR 
Aorta 
SLA resin (smooth finishing) White 
Thermoplastic (rougher finishing) White 
Nylon (selective laser sintering technique) White 
Right ventricular  
outflow tract 
SLA resin (smooth finishing); hollow lumen White 
Thermoplastic (rougher finishing); filled lumen White 
Watershed® resin (smooth finishing) Transparent  
TangoPlus® (rubber-like) Opaque 
Aorta  
+ left ventricle 
Powder print  Blue 
Pulmonary artery  
+ right ventricle 
Powder print Red 
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Table 2 
Nurses ranking of 3D patient-specific models’ usefulness for understanding the 
anatomy of different conditions, on a scale 1-7 (where 7 = extremely useful). 
 
 
MODEL RANKING SCORING (MEAN±SD) 
Aortic coarctation 1 6.0±0.8 
Hypoplastic left heart syndrome (stage I) 2 5.8±0.8 
Control anatomy (healthy anatomy) 3 5.7±1.2 
Hypoplastic left heart syndrome (stage II) 4 5.6±0.5 
Hypoplastic left heart syndrome (stage III) 5 5.5±0.5 
Transposition of the great arteries 5 5.5±1.3 
Pulmonary atresia 7 4.9±1.2 
Tetralogy of Fallot 8 4.8±1.1 
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Figure legends 
 
Figure 1: (A) Engagement activity with young people making 3D heart with play-doh 
and (B) producing a range of 3D heart models as an ice-breaking activity for a workshop 
with CHD patients. (C) Collecting feedback from patients with CHD on paper 
tablecloths, discussing different models (in this picture: three different models of right 
ventricular outflow tracts).  
 
Figure 2: Models manufactured for training purpose, as shown to a group of nurses, 
representing a range of congenital heart defects. Models not in scale but for illustrative 
purposes only. (TGA = transposition of the great arteries, ToF = tetralogy of Fallot, 
CoA = coarctation of the aorta, HLHS = hypoplastic left heart syndrome, TCPC = total 
cavopulmonary connection) 
 
Figure 3: A range of models is prepared for being discussed amongst a group of 
parents of patients with CHD.  
 
Figure 4: Clinicians rating of usefulness of 3D patient-specific models before and 
after a workshop discussing 3D modelling from medical imaging.  
 
Figure 5: Clinicians’ ranking of relevant applications of patient-specific models 
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